EU signs contract for new Spanish COVID vaccine

Credit: Pixabay/CC0 Public Domain

The European Commission has signed an agreement to allow EU member states to buy 250 million doses of the new COVID-19 vaccine produced in Spain, said Tuesday.

The European Medicines Agency (EMA) has not yet approved the HIPRA vaccine, but it will green light It will be the eighth participating in the EU cooperation program.

The EU’s top official in Brussels is monitoring the joint procurement strategy that has confirmed 4.2 vaccines against COVID-19 so far, which strengthens the group’s prevention strategy.

Contracts have already been signed with AstraZeneca, Sanofi-GSK, Janssen, BioNtech-Pfizer, Moderna, Novavax and Valneva, although the latter has stopped production.

The HIPRA vaccine, also known as PHH-1V, is protein-based and is intended as a booster shots for adults whose immunity wanes after the first two or three shots.

The EMA has put it on “review” and is reviewing the laboratory results as well clinical trialswith the aim of possibly granting permission to use it later this year.

“With the number of COVID-19 cases increasing in Europe, we need to ensure full preparedness as we move into the autumn and winter months,” said EU Health Commissioner Stella Kyriakides.

“The HIPRA vaccine adds another option to complement our portfolio of vaccines for our Members and citizens. Strengthening immunization and growth is critical in the coming months.”

Spanish Prime Minister Pedro Sanchez, who is speaking to the press during his visit to Palma de Mallorca, seized the contract as a sign of its imminent approval, saying: “We have finally achieved this prevention.”

He hailed Brussels’ approval as a victory for “calculation and pharmaceutical industry in our country” and public research funding from the national and Catalan governments.

EU regulator begins review of Spain’s COVID vaccine stimulus

© 2022 AFP

hint: EU signs contract for new Spanish COVID vaccine (2022, August 2) Retrieved 2 August 2022 from

This document is subject to copyright. Except for any bona fide transaction for research or investigation purposes, no part may be reproduced without written permission. Content is provided for informational purposes only.

EU signs contract for new Spanish COVID vaccine Source link EU signs contract for new Spanish COVID vaccine

Related Articles

Back to top button